[Skip to Content]
[Skip to Content Landing]
May 1979

On Treating Glomerulonephritis

Arch Intern Med. 1979;139(5):509. doi:10.1001/archinte.1979.03630420005003

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


A patient seeks treatment for hematuria and proteinuria and undergoes diagnostic examination that excludes urologic lesions and does not reveal characteristic findings of specific renal diseases, such as acute poststreptococcal glomerulonephritis. To clarify further the nature of the disease, a renal biopsy is performed. It is naive to anticipate that renal histopathology will regularly provide a diagnosis. Of course, recognition of amyloid or diabetic nephropathy identifies lesions, the natural histories of which are well known. More often a combination of immunofluorescent staining for inimunoglobulins or fibrin or both, coupled with assessment of proliferation of the distinct types of intraglomerular cells, allows a descriptive pathologic diagnosis, such as membranous glomerulopathy, IgA mesangial glomerulonephritis, or the crescentic form of proliferative glomerulonephritis, which is also called rapidly progressive glomerulonephritis. These lesions have multiple causes. For example, IgA nephritis may be the renal lesion of Henoch-Schönlein purpura, of systemic lupus erythematosus, or of Berger's

First Page Preview View Large
First page PDF preview
First page PDF preview